Why does type 1 diabetes carry an increased risk of other autoimmune diseases?
Type 1 diabetes is itself an autoimmune disease: your immune system mistakenly attacks the beta cells in the pancreas, the ones that produce insulin. The same inherited genetic predisposition (especially the genes in the HLA region) and the same loss of immune tolerance — the mechanism by which the body learns not to attack itself — can affect other organs too [1]. In practice, the presence of type 1 diabetes indicates a tendency of the immune system to attack the body's own tissues, which does not always stay limited to the pancreas [2].
The most commonly targeted are the thyroid, the gut and the stomach. For this reason, the autoimmune diseases associated with type 1 diabetes are looked for periodically, even in the absence of symptoms. Early detection allows more effective treatment and prevents complications from developing [2].
What is autoimmune polyendocrine syndrome (APS)?
Autoimmune polyendocrine syndrome (abbreviated APS) brings together several diseases in which the immune system attacks multiple glands and organs in the same person. The most commonly affected are the glands that produce hormones, such as the thyroid, the adrenal glands and the pancreas. Hence the name: “poly” means several, and “endocrine” refers to the hormonal glands [3].
An important practical aspect is that these conditions do not all appear at the same time. Years or even decades can pass between one disease and the next, which is why APS is a diagnosis that evolves over the course of a lifetime and requires continuous monitoring. There are several subtypes of APS (1, 2 and 3), which differ in the age of onset, the genetic cause and the combination of diseases [3].
What are the differences between APS-1, APS-2 and APS-3?
APS-1 is the rarest form and usually appears in childhood. It is caused by a single defective gene (called AIRE) and is recognised by three typical signs: repeated fungal infections of the skin and mucous membranes, poorly functioning parathyroid glands (with a fall in calcium) and Addison's disease (adrenal insufficiency). Type 1 diabetes can also appear in some of these patients [4].
APS-2 is the most common form, appears in adults, especially in women, and involves several genes; it always includes Addison's disease, to which autoimmune thyroid disease and/or type 1 diabetes are added. APS-3 obligatorily comprises thyroid involvement plus another autoimmune disease (such as type 1 diabetes) but, by definition, without Addison's disease. Most people who have type 1 diabetes and a thyroid disease at the same time fall into APS-3 [3].
How common is Hashimoto's thyroiditis in type 1 diabetes?
Hashimoto's thyroiditis is the most common autoimmune disease associated with type 1 diabetes. The immune system attacks the thyroid, which sometimes leads to a smaller thyroid that produces too few thyroid hormones (hypothyroidism). The specific antibodies (anti-TPO, anti-TG) appear in the blood many years before thyroid function begins to decline [5], and thyroid autoantibodies are found in about one in four patients with type 1 diabetes [6].
The signs of hypothyroidism include fatigue, feeling cold and, in children, slowed growth; however, they do not appear as long as thyroid function is normal, and the mere presence of antibodies causes no symptoms. For you, an important aspect is that an underactive thyroid can increase the risk of hypoglycaemia. Treatment is simple and consists of replacing the missing hormone with levothyroxine, and the thyroid is checked shortly after the diagnosis of type 1 diabetes and then annually [5].
Does Graves' disease also occur in association with type 1 diabetes?
Yes, but much more rarely than Hashimoto's thyroiditis. Graves' disease is, in a way, the opposite of Hashimoto's thyroiditis: the thyroid becomes overactive (hyperthyroidism) because certain antibodies stimulate it to produce thyroid hormones in excess [5].
The signs of hyperthyroidism include weight loss despite a good appetite, palpitations, feeling hot, tremor, restlessness and, sometimes, bulging eyes. An overactive thyroid makes blood glucose harder to control, with a tendency to hyperglycaemia. Both Graves' disease and Hashimoto's thyroiditis are forms of autoimmune thyroid disease and can, occasionally, affect the same person at different times in life [7].
How common is celiac disease in type 1 diabetes?
Celiac disease is considerably more common in people with type 1 diabetes than in the general population. It is a reaction of the immune system to gluten — a protein in wheat, barley and rye — that damages the lining of the small intestine [8].
An important particularity in people with type 1 diabetes is that celiac disease is often silent: many people have no digestive symptoms at all. That is why a blood test (anti-transglutaminase antibodies of the IgA type, together with total IgA) is recommended instead of waiting for symptoms to appear. Untreated, the disease can cause fatigue, anaemia, reduced bone strength, poor growth in children and unexplained hypoglycaemia, and the treatment is a gluten-free diet maintained for life [9].
How do we recognise Addison's disease?
Addison's disease (adrenal insufficiency) is, fortunately, very rare, but at the same time very dangerous. The immune system attacks the adrenal glands, which can no longer produce enough cortisol, a hormone essential for survival [3].
The signs of cortisol deficiency include persistent fatigue, weight loss, low blood pressure, dizziness on standing up, a craving for salt and a characteristic darkening of the skin colour. A special warning sign for you, if you have type 1 diabetes, is repeated and unexplained hypoglycaemia, accompanied by a decrease in insulin requirements — because cortisol normally opposes insulin and raises blood glucose. Any of these signs requires prompt medical assessment, and the treatment consists of replacing the missing hormones [6].
Does vitiligo occur more often in type 1 diabetes?
Yes. Vitiligo means well-defined white patches on the skin, which appear because the immune system destroys the cells that give the skin its colour (melanocytes). This condition is more common in people with type 1 diabetes than in the general population [6].
Vitiligo often appears together with autoimmune conditions of the thyroid, the stomach or the adrenal glands. It does not endanger physical health, but it can affect self-image and emotional state. In addition, its presence signals a broader autoimmune tendency, which is useful to recognise and follow [10].
What is pernicious anaemia?
Pernicious anaemia is a type of anaemia caused by a lack of vitamin B12, which arises because of an autoimmune attack on the stomach. The immune system attacks the cells of the stomach, and the stomach can no longer help absorb vitamin B12 from food [11].
The signs include fatigue, pallor, a burning tongue and neurological symptoms such as numbness or tingling (which can appear even before the anaemia). It is one of the relatively common autoimmune associations in type 1 diabetes, which is why doctors look for it early, and the treatment is simple and consists of giving vitamin B12 [12].
What other rarer associations with type 1 diabetes exist?
Besides the common conditions, the immune system can occasionally attack other organs too. The liver (autoimmune hepatitis), the joints (rheumatoid arthritis or juvenile arthritis), the skin (psoriasis) or the hair (alopecia areata — patchy hair loss) can be affected [10].
Even rarer are the conditions involving the nerves and muscles (myasthenia gravis, multiple sclerosis) or the lack of an entire class of antibodies (IgA deficiency) — the latter being important because it influences the way celiac disease is tested for. These associations are unusual, and testing for them is done according to symptoms, not routinely [13].
How often should screening for the associated autoimmune diseases be done?
For the thyroid, testing is done shortly after the diagnosis of type 1 diabetes, then usually annually — or more often if symptoms appear or if antibodies are already present. For celiac disease, testing is recommended at the time of diagnosis, then repeated during the first years (usually at two and at five years), and afterwards only if suggestive symptoms appear [14].
For the rarer conditions, such as Addison's disease, no routine screening is done, only when symptoms raise a suspicion. The general rule is continuous surveillance, throughout life, because a new autoimmune disease can appear at any time [2].
Can the associations appear at any time or only within certain age windows?
These associations can appear at any moment in life, without there being an age after which the risk disappears. Some autoimmune diseases may already be present at the time of the type 1 diabetes diagnosis, but as a rule they appear years or decades later — which is precisely why continuous surveillance is so important [15].
There are, however, a few patterns: celiac disease tends to appear earlier, in the first years after diagnosis, while thyroid diseases, pernicious anaemia and joint conditions become relatively more common with advancing age and with a longer duration of diabetes. People diagnosed with type 1 diabetes at an older age and women have a somewhat greater chance of developing an additional autoimmune disease [16].
Conclusions
- Type 1 diabetes is itself an autoimmune disease, and the same genetic predisposition (especially HLA) and loss of immune tolerance explain the increased risk of developing other autoimmune diseases too [1] [2].
- The most commonly affected are the thyroid (Hashimoto, more rarely Graves'), the gut (celiac disease) and the stomach (autoimmune gastritis / pernicious anaemia) [5] [8] [11].
- About 20–30% of people with type 1 diabetes have at least one other autoimmune disease, Hashimoto's thyroiditis being the most common association [6].
- Many associations are silent at first, which is why screening (thyroid, celiac disease) is done early and repeated periodically, according to the guidelines [14].
- The associations can appear at any age, which makes surveillance throughout life necessary [15] [16].
You might also be interested in:
Other pages available in the domain of autoimmunity in type 1 diabetes
Autoantibodies in type 1 diabetes
Cellular autoimmunity in type 1 diabetes
References
- Association of HLA Haplotypes with Autoimmune Pathogenesis in Newly Diagnosed Type 1 Romanian Diabetic Children: A Pilot, Single-Center Cross-Sectional Study. Life (Basel). 2024;14(6):781. PubMed
- Type 1 Diabetes and Other Autoimmune Diseases—Epidemiology, Pathophysiology and Screening. Endocrinol Diabetes Metab. 2026;9(1):e70119. PubMed
- Autoimmune polyendocrine syndromes. Autoimmun Rev. 2014;13(2):85-9. PubMed
- Autoimmune polyendocrine syndrome type 1: Clinical manifestations, pathogenetic features, and management approach. Autoimmun Rev. 2022;21(8):103135. PubMed
- Thyroid Dysfunction and Diabetes Mellitus: Two Closely Associated Disorders. Endocr Rev. 2019;40(3):789-824. PubMed
- Associated auto-immune disease in type 1 diabetes patients: a systematic review and meta-analysis. Eur J Endocrinol. 2019;180(2):135-144. PubMed
- Association of autoimmune thyroid disease with type 1 diabetes mellitus and its ultrasonic diagnosis and management. World J Diabetes. 2024;15(3):348-360. PubMed
- Prevalence of celiac disease in children with type 1 diabetes: A review. Diabetes Metab Syndr. 2021;15(3):969-974. PubMed
- Celiac Disease-Related Conditions: Who to Test? Gastroenterology. 2024;167(1):64-78. PubMed
- Type 1 Diabetes and Other Autoimmune Disorders in Children. Pediatr Diabetes. 2024;2024:5082064. PubMed
- Autoimmune gastritis in type 1 diabetes: a clinically oriented review. J Clin Endocrinol Metab. 2008;93(2):363-71. PubMed
- Significance of an Early Diagnosis of Autoimmune Gastritis in Nonelderly Patients with Type 1 Diabetes Mellitus and Autoimmune Thyroid Disease. Intern Med. 2025;64(17):2587-2591. PubMed
- Additional autoimmune diseases associated with type 1 diabetes in children and adolescents: A French single-center study from 2014 to 2021. Arch Pediatr. 2022;29(5):381-387. PubMed
- 14. Children and Adolescents: Standards of Care in Diabetes—2026. Diabetes Care. 2026;49(Suppl 1):S297-S320. PubMed
- Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK. Lancet. 2023;401(10391):1878-1890. PubMed
- Autoimmune comorbidity in type 1 diabetes and its association with metabolic control and mortality risk in young people: a population-based study. Diabetologia. 2024;67(4):679-689. PubMed